ÇEKİÇ, Ş. Et Al. 2019. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?. TURKISH JOURNAL OF PEDIATRICS , vol.61, no.6 , 937-940.

ÇEKİÇ, Ş., ÖZGÜR, T., Karali, Y., Ozkan, T., & Kilic, S. Ş., (2019). Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?. TURKISH JOURNAL OF PEDIATRICS , vol.61, no.6, 937-940.

ÇEKİÇ, ŞÜKRÜ Et Al. "Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?," TURKISH JOURNAL OF PEDIATRICS , vol.61, no.6, 937-940, 2019

ÇEKİÇ, ŞÜKRÜ Et Al. "Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?." TURKISH JOURNAL OF PEDIATRICS , vol.61, no.6, pp.937-940, 2019

ÇEKİÇ, Ş. Et Al. (2019) . "Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?." TURKISH JOURNAL OF PEDIATRICS , vol.61, no.6, pp.937-940.

@article{article, author={ŞÜKRÜ ÇEKİÇ Et Al. }, title={Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?}, journal={TURKISH JOURNAL OF PEDIATRICS}, year=2019, pages={937-940} }